Lyra Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2020 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Lyra Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2020 to Q3 2024.
Lyra Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 439 %, a 33.5% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	439	-221	-33.5%	Sep 30, 2024
Q2 2024	480	-259	-35%	Jun 30, 2024
Q1 2024	582	-213	-26.8%	Mar 31, 2024
Q4 2023	615	-4.75	-0.77%	Dec 31, 2023
Q3 2023	660	+158	+31.5%	Sep 30, 2023
Q2 2023	739	+342	+86.4%	Jun 30, 2023
Q1 2023	795	+452	+132%	Mar 31, 2023
Q4 2022	620	+85.8	+16.1%	Dec 31, 2022
Q3 2022	502	-336	-40.1%	Sep 30, 2022
Q2 2022	396	-1.11K	-73.8%	Jun 30, 2022
Q1 2022	343	-1.44K	-80.8%	Mar 31, 2022
Q4 2021	534	-987	-64.9%	Dec 31, 2021
Q3 2021	838	-311	-27.1%	Sep 30, 2021
Q2 2021	1.51K			Jun 30, 2021
Q1 2021	1.79K			Mar 31, 2021
Q4 2020	1.52K			Dec 31, 2020
Q3 2020	1.15K			Sep 30, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.